{"id":50928,"date":"2022-11-16T11:02:18","date_gmt":"2022-11-16T10:02:18","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\/"},"modified":"2022-11-16T11:02:18","modified_gmt":"2022-11-16T10:02:18","slug":"global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\/","title":{"rendered":"Global Pruritus Therapeutics Market Report 2022: Significant Investments in R&amp;D Drive Continued Growth &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5671229\/pruritus-therapeutics-market-by-drug-type-by?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=82l6bn&amp;utm_campaign=1776634+-+Global+Pruritus+Therapeutics+Market+Report+2022%3A+Significant+Investments+in+R%26D+Drive+Continued+Growth&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Pruritus Therapeutics Market By Drug type, By Disease Type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221116005504\/en\/1639479\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221116005504\/en\/1639479\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global pruritus therapeutics market was valued at $7,849.4 million in 2021, and is projected to reach $11,186.15 million by 2031, registering a CAGR of 3.6% from 2022 to 2031.\n<\/p>\n<p>\nMedical professionals have utilized corticosteroids as a topical dosage form for treating pruritus for many years. The first-line pharmacological therapy for pruritus and associated skin itch diseases such as AD, allergic contact dermatitis, and lichen planus is corticosteroids. Pruritus, a common sign of autoimmune and inflammatory skin conditions, can be extremely uncomfortable and negatively affect a patient&#8217;s quality of life. Moisturizers, emollients, and barrier repair creams usually lessen pruritus by enhancing barrier function.\n<\/p>\n<p>\nLeading market players are significantly investing in research and development to create innovative pruritus therapies. Investments are also being made to advance existing therapeutics. In addition, launching new medications and building a strong product pipeline is the major focus of key players. Moreover, owing to their low cost and convenience of availability, over-the-counter topical medicines are in high demand. As a result, patients are turning more frequently to over-the-counter treatments. These drivers provide a favorable environment for increasing sales of pruritus products and for growth of the overall market. However, lack of knowledge regarding cause of the disease creates hindrance to the market. Moreover, patent expiry of various pruritus therapeutic products provide a greater opportunity for market players to grow their business.\n<\/p>\n<p>\n<strong>Key Market Segments<\/strong>\n<\/p>\n<p>\n<strong>By Drug type<\/strong>\n<\/p>\n<ul>\n<li>\nCorticosteroids\n<\/li>\n<li>\nAntihistamines\n<\/li>\n<li>\nLocal Anesthetics\n<\/li>\n<li>\nImmunosuppressant\n<\/li>\n<li>\nOthers\n<\/li>\n<\/ul>\n<p>\n<strong>By Disease Type<\/strong>\n<\/p>\n<ul>\n<li>\nAtopic Dermatitis\n<\/li>\n<li>\nAllergic Contact Dermatitis\n<\/li>\n<li>\nUrticaria\n<\/li>\n<li>\nOthers\n<\/li>\n<\/ul>\n<p>\n<strong>By Distribution Channel<\/strong>\n<\/p>\n<ul>\n<li>\nHospital Pharmacies\n<\/li>\n<li>\nDrug stores Retail Pharmacies\n<\/li>\n<li>\nRoute of Administration\n<\/li>\n<li>\nOral\n<\/li>\n<li>\nParenteral\n<\/li>\n<li>\nTopical\n<\/li>\n<li>\nOnline providers\n<\/li>\n<\/ul>\n<p>\n<strong>By Region<\/strong>\n<\/p>\n<ul>\n<li>\nNorth America\n<\/li>\n<li>\nU.S.\n<\/li>\n<li>\nCanada\n<\/li>\n<li>\nMexico\n<\/li>\n<li>\nEurope\n<\/li>\n<li>\nFrance\n<\/li>\n<li>\nUK\n<\/li>\n<li>\nItaly\n<\/li>\n<li>\nSpain\n<\/li>\n<li>\nRest of Europe\n<\/li>\n<li>\nGermany\n<\/li>\n<li>\nAsia-Pacific\n<\/li>\n<li>\nJapan\n<\/li>\n<li>\nChina\n<\/li>\n<li>\nAustralia\n<\/li>\n<li>\nIndia\n<\/li>\n<li>\nSouth Korea\n<\/li>\n<li>\nRest of Asia-Pacific\n<\/li>\n<li>\nLAMEA\n<\/li>\n<li>\nBrazil\n<\/li>\n<li>\nSaudi Arabia\n<\/li>\n<li>\nSouth Africa\n<\/li>\n<li>\nRest of LAMEA\n<\/li>\n<\/ul>\n<p>\n<strong>Key Market Players<\/strong>\n<\/p>\n<ul>\n<li>\nAbbVie Inc.\n<\/li>\n<li>\nAmgen Inc.\n<\/li>\n<li>\nBausch Health Companies Inc.\n<\/li>\n<li>\nCara therapeutics, Inc.\n<\/li>\n<li>\nCipla Ltd.\n<\/li>\n<li>\nEilly Lilly and company\n<\/li>\n<li>\nEvelo Biosciences\n<\/li>\n<li>\nGalderma S.A.\n<\/li>\n<li>\nLEO Pharma\n<\/li>\n<li>\nMC2 therapeuitics\n<\/li>\n<li>\nNovan, Inc\n<\/li>\n<li>\nNovartis AG\n<\/li>\n<li>\nPfizer Inc.\n<\/li>\n<li>\nRegeneron Pharmaceuticals, Inc\n<\/li>\n<li>\nSanofi\n<\/li>\n<li>\nTrevi therapeutics\n<\/li>\n<li>\nViatris Inc. (Mylan NV)\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 1: INTRODUCTION<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 2: EXECUTIVE SUMMARY<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 3: MARKET OVERVIEW<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 4: PRURITUS THERAPEUTICS MARKET, BY DRUG TYPE<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 5: PRURITUS THERAPEUTICS MARKET, BY DISEASE TYPE<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 6: PRURITUS THERAPEUTICS MARKET, BY DISTRIBUTION CHANNEL<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 7: PRURITUS THERAPEUTICS MARKET, BY REGION<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 8: COMPANY LANDSCAPE<\/strong>\n<\/p>\n<p>\n<strong>CHAPTER 9: COMPANY PROFILES<\/strong>\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAbbvie Inc.\n<\/li>\n<li>\nAmgen Inc.\n<\/li>\n<li>\nBausch Health Companies Inc.\n<\/li>\n<li>\nCara Therapeutics, Inc.\n<\/li>\n<li>\nCipla Ltd.\n<\/li>\n<li>\nEilly Lilly and Company\n<\/li>\n<li>\nEvelo Biosciences\n<\/li>\n<li>\nGalderma S.A.\n<\/li>\n<li>\nLeo Pharma\n<\/li>\n<li>\nMc2 Therapeuitics\n<\/li>\n<li>\nNovan, Inc\n<\/li>\n<li>\nNovartis AG\n<\/li>\n<li>\nPfizer Inc.\n<\/li>\n<li>\nRegeneron Pharmaceuticals, Inc\n<\/li>\n<li>\nSanofi\n<\/li>\n<li>\nTrevi Therapeutics\n<\/li>\n<li>\nViatris Inc. (Mylan Nv)\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5671229\/pruritus-therapeutics-market-by-drug-type-by?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=82l6bn&amp;utm_campaign=1776634+-+Global+Pruritus+Therapeutics+Market+Report+2022%3A+Significant+Investments+in+R%26D+Drive+Continued+Growth&amp;utm_exec=como322prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/y0fg4k<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"mailto:press&#64;researchand&#109;&#97;&#114;&#107;&#101;&#116;&#115;&#46;&#99;&#111;&#109;\" rel=\"nofollow noopener\" shape=\"rect\">p&#114;&#x65;&#x73;s&#64;&#114;&#x65;&#x73;e&#97;&#114;&#x63;&#x68;a&#110;&#x64;&#x6d;&#x61;r&#107;&#x65;&#x74;s&#46;&#99;&#x6f;&#x6d;<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Pruritus Therapeutics Market By Drug type, By Disease Type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global pruritus therapeutics market was valued at $7,849.4 million in 2021, and is projected to reach $11,186.15 million by 2031, registering a CAGR of 3.6% from &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-50928","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Pruritus Therapeutics Market Report 2022: Significant Investments in R&amp;D Drive Continued Growth - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Pruritus Therapeutics Market Report 2022: Significant Investments in R&amp;D Drive Continued Growth - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Pruritus Therapeutics Market By Drug type, By Disease Type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global pruritus therapeutics market was valued at $7,849.4 million in 2021, and is projected to reach $11,186.15 million by 2031, registering a CAGR of 3.6% from ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-11-16T10:02:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221116005504\/en\/1639479\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Pruritus Therapeutics Market Report 2022: Significant Investments in R&amp;D Drive Continued Growth &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-11-16T10:02:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\\\/\"},\"wordCount\":530,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221116005504\\\/en\\\/1639479\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\\\/\",\"name\":\"Global Pruritus Therapeutics Market Report 2022: Significant Investments in R&amp;D Drive Continued Growth - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221116005504\\\/en\\\/1639479\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-11-16T10:02:18+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221116005504\\\/en\\\/1639479\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221116005504\\\/en\\\/1639479\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Pruritus Therapeutics Market Report 2022: Significant Investments in R&amp;D Drive Continued Growth &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Pruritus Therapeutics Market Report 2022: Significant Investments in R&amp;D Drive Continued Growth - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Pruritus Therapeutics Market Report 2022: Significant Investments in R&amp;D Drive Continued Growth - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Pruritus Therapeutics Market By Drug type, By Disease Type, By Distribution Channel: Global Opportunity Analysis and Industry Forecast, 2021-2031&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global pruritus therapeutics market was valued at $7,849.4 million in 2021, and is projected to reach $11,186.15 million by 2031, registering a CAGR of 3.6% from ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-11-16T10:02:18+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221116005504\/en\/1639479\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Pruritus Therapeutics Market Report 2022: Significant Investments in R&amp;D Drive Continued Growth &#8211; ResearchAndMarkets.com","datePublished":"2022-11-16T10:02:18+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\/"},"wordCount":530,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221116005504\/en\/1639479\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\/","name":"Global Pruritus Therapeutics Market Report 2022: Significant Investments in R&amp;D Drive Continued Growth - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221116005504\/en\/1639479\/21\/logo.jpg","datePublished":"2022-11-16T10:02:18+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221116005504\/en\/1639479\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221116005504\/en\/1639479\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-pruritus-therapeutics-market-report-2022-significant-investments-in-rd-drive-continued-growth-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Pruritus Therapeutics Market Report 2022: Significant Investments in R&amp;D Drive Continued Growth &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50928","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=50928"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/50928\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=50928"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=50928"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=50928"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}